ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1053

Impact of Step Therapy Protocols on North Carolina Rheumatologists’ Job Satisfaction and the Quality of Care Received By Their Patients with Rheumatoid Arthritis

Victoria Hamby1, Amanda Nelson2, Antonia Bennett1, Leigh F. Callahan3 and Stacie Dusetzina4, 1Gillings School of Global Public Health, Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Division of Rheumatology, Allergy, and Immunology and Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Eshelman School of Pharmacy and Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Advocacy, healthcare policy, pharmacotherapy and prior authorization

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Health Services Research Poster II: Osteoarthritis and Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Early diagnosis and treatment of rheumatoid arthritis (RA) is crucial in minimizing disease damage. Step-therapy, a form of prior authorization used by payers to manage costs, determines which medications will be covered and thus affordable. Expansion of the Institute for Healthcare Improvements Triple Aim initiative to the Quadruple Aim initiative added the aim to promote workplace happiness for providers. We examined provider beliefs regarding the role of step-therapy in managing health care costs, quality of care delivered, and on clinical autonomy and job satisfaction in North Carolina. We also evaluated provider awareness and agreement with proposed state policies aimed at streamlining step-therapy exceptions processes.

Methods: In this cross-sectional survey study, a web-based questionnaire was emailed on March 7 and March 16, 2017 to all members of the North Carolina Rheumatology Association. We summarized the data through frequency counts to determine knowledge, beliefs and perception of step-therapy, and chi-square tests were used to compare respondent knowledge of state legislation, NC HB 1048, to their beliefs about autonomy and job satisfaction.

Results: The survey was sent to 118 providers, and the final analysis included 38 completed surveys (effective response rate of 32.2%). Respondents were more likely to be male (58%), report 20+ years in practice (53%), work in a private practice (87%), and see patients with Medicare (34%) or private insurance (38%). Providers disagreed that step-therapy reduced costs for society overall (52%) or patients (57%). Instead, 82% agreed that step-therapy reduced costs for insurance companies. With respect to quality, 92% of providers believed step-therapy negatively impacted the quality of care provided to patients (50% somewhat reduced quality, 42% greatly reduced quality) and 82% of providers agreed that step-therapy delayed beginning proper treatment (50% agree, 31% strongly agree). Nearly 90% of providers reported step-therapy negatively affects their autonomy and 87% reported step-therapy negatively impacting their job satisfaction. When considering the burden of step-therapy on providers, 79% of providers reported step-therapy as being common when prescribing for RA. Most respondents (76%) were directly involved in processing step-therapy paperwork. In addition, half of respondents reported spending >60 minutes on step-therapy paperwork in an average clinic day. Despite the burden of step-therapy, only 47% of providers were aware of proposed NC state legislation to reduce the burden of step-therapy. Notably nearly all surveyed providers agreed with the exceptions proposed within the state legislation.

Conclusion: Providers view step-therapy as a burden without justifiable results for cost and quality. This unjustified burden coupled with provider agreement with state proposed legislation suggests that providers should engage with policy makers to support legislative action on this topic. Additionally, provider groups such as the ACR should create advocacy groups to increase awareness of state and federal legislation.


Disclosure: V. Hamby, None; A. Nelson, QuantiaMD, 9,NIAMS-NIH, 2,RRF, 2; A. Bennett, None; L. F. Callahan, None; S. Dusetzina, None.

To cite this abstract in AMA style:

Hamby V, Nelson A, Bennett A, Callahan LF, Dusetzina S. Impact of Step Therapy Protocols on North Carolina Rheumatologists’ Job Satisfaction and the Quality of Care Received By Their Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/impact-of-step-therapy-protocols-on-north-carolina-rheumatologists-job-satisfaction-and-the-quality-of-care-received-by-their-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-step-therapy-protocols-on-north-carolina-rheumatologists-job-satisfaction-and-the-quality-of-care-received-by-their-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology